Literature DB >> 16204278

Klotho reduces apoptosis in experimental ischaemic acute renal failure.

Hidekazu Sugiura1, Takumi Yoshida, Ken Tsuchiya, Michihiro Mitobe, Sayoko Nishimura, Satsuki Shirota, Takashi Akiba, Hiroshi Nihei.   

Abstract

BACKGROUND: Klotho is associated with the suppression of several ageing phenotypes. Because high klotho gene expression was detected in the kidney and several studies have found altered expression in animal models, we explored the physiological relevance of klotho expression in the kidney under renal ischemia reperfusion injury (IRI).
METHODS: Male Wistar rats were subjected to bilateral renal ischemia or sham operation, followed by reperfusion for 6, 12 or 24 h, or 2 to 10 days. Renal expression of klotho was assessed by real-time PCR or Western blotting. Creatinine levels were determined. Immunohistochemical studies and TUNEL staining were performed. An adenovirus harbouring the mouse klotho gene (ad-kl) was intravenously administered to one group of rats before renal IRI.
RESULTS: Renal klotho mRNA and protein expressions were significantly reduced in IRI rats the first day after ischemia. Pre-treatment with ad-kl resulted in a robust induction of klotho mRNA and protein in the liver but not in the kidney. Ad-kl gene transfer improved serum creatinine and the histological changes. Apoptosis induced by IRI was attenuated following ad-kl administration.
CONCLUSION: The data suggest klotho to be involved in the pathophysiology of IRI. Downregulation of renal klotho exacerbates ischaemic acute renal failure, and klotho gene induction has therapeutic potential in managing ischaemic renal damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204278     DOI: 10.1093/ndt/gfi165

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  72 in total

Review 1.  Klotho as a potential biomarker and therapy for acute kidney injury.

Authors:  Ming-Chang Hu; Orson W Moe
Journal:  Nat Rev Nephrol       Date:  2012-06-05       Impact factor: 28.314

2.  Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective.

Authors:  Ming-Chang Hu; Mingjun Shi; Jianning Zhang; Henry Quiñones; Makoto Kuro-o; Orson W Moe
Journal:  Kidney Int       Date:  2010-09-22       Impact factor: 10.612

Review 3.  Role of Klotho in aging, phosphate metabolism, and CKD.

Authors:  George B John; Chung-Yi Cheng; Makoto Kuro-o
Journal:  Am J Kidney Dis       Date:  2011-04-15       Impact factor: 8.860

Review 4.  Phosphate Toxicity in CKD: The Killer among Us.

Authors:  Cynthia S Ritter; Eduardo Slatopolsky
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-10       Impact factor: 8.237

5.  Beclin 1/Bcl-2 complex-dependent autophagy activity modulates renal susceptibility to ischemia-reperfusion injury and mediates renoprotection by Klotho.

Authors:  Peng Li; Mingjun Shi; Jenny Maique; Joy Shaffer; Shirley Yan; Orson W Moe; Ming Chang Hu
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-27

6.  Renal Production, Uptake, and Handling of Circulating αKlotho.

Authors:  Ming Chang Hu; Mingjun Shi; Jianning Zhang; Tayo Addo; Han Ju Cho; Sarah L Barker; Priya Ravikumar; Nancy Gillings; Ao Bian; Sachdev S Sidhu; Makoto Kuro-o; Orson W Moe
Journal:  J Am Soc Nephrol       Date:  2015-05-14       Impact factor: 10.121

7.  Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling.

Authors:  Minoru Satoh; Hajime Nagasu; Yoshitaka Morita; Terry P Yamaguchi; Yashpal S Kanwar; Naoki Kashihara
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-03

Review 8.  Klotho and aging.

Authors:  Makoto Kuro-o
Journal:  Biochim Biophys Acta       Date:  2009-02-20

9.  Decrease of Klotho in the kidney of streptozotocin-induced diabetic rats.

Authors:  Meng-Fu Cheng; Li-Jen Chen; Juei-Tang Cheng
Journal:  J Biomed Biotechnol       Date:  2010-06-27

10.  Protective effect of selaginellin on glutamate-induced cytotoxicity and apoptosis in differentiated PC12 cells.

Authors:  Chen-Jing Wang; Chang-Ping Hu; Kang-Ping Xu; Qiong Yuan; Fu-Shuang Li; Hui Zou; Gui-Shan Tan; Yuan-Jian Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-20       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.